| 34.94 -0.11 (-0.31%) | 01-14 13:03 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 41.81 | 1-year : | 48.83 |
| Resists | First : | 35.79 | Second : | 41.81 |
| Pivot price | 34.24  |
|||
| Supports | First : | 34 |
Second : | 32.9 |
| MAs | MA(5) : | 35.11 |
MA(20) : | 34.4  |
| MA(100) : | 33.93 |
MA(250) : | 35.87 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 81.6 |
D(3) : | 81.5 |
| RSI | RSI(14): 60.3 | |||
| 52-week | High : | 45.75 | Low : | 29.04 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ GMRE ] has closed below upper band by 23.3%. Bollinger Bands are 27.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 35.42 - 35.61 | 35.61 - 35.77 |
| Low: | 34.34 - 34.56 | 34.56 - 34.74 |
| Close: | 34.7 - 35.06 | 35.06 - 35.37 |
Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Sun, 11 Jan 2026
Global Medical REIT launches Series B preferred stock offering - MSN
Sun, 11 Jan 2026
Global Medical REIT Inc. (NYSE:GMRE) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Sun, 11 Jan 2026
141,934 Shares in Global Medical REIT Inc. $GMRE Acquired by Peregrine Capital Management LLC - MarketBeat
Sun, 11 Jan 2026
Global Medical REIT Inc. $GMRE Position Trimmed by Asset Management One Co. Ltd. - MarketBeat
Tue, 06 Jan 2026
Global Medical REIT: Attractively Priced Preferred Shares (NYSE:GMRE.PR.A) - Seeking Alpha
Tue, 06 Jan 2026
Global Medical REIT: Buy This 9% Yield While The Market Ignores Value (NYSE:GMRE) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Real Estate
|
|
|
Industry:
REIT - Healthcare Facilities
|
|
| Shares Out | 13 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 6 (%) |
| Held by Institutions | 71.3 (%) |
| Shares Short | 713 (K) |
| Shares Short P.Month | 813 (K) |
| EPS | -0.26 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 30.61 |
| Profit Margin | 1.7 % |
| Operating Margin | 24.4 % |
| Return on Assets (ttm) | 1.7 % |
| Return on Equity (ttm) | 0.4 % |
| Qtrly Rev. Growth | 8.6 % |
| Gross Profit (p.s.) | 10.78 |
| Sales Per Share | 10.8 |
| EBITDA (p.s.) | 6.52 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 73 (M) |
| Levered Free Cash Flow | 66 (M) |
| PE Ratio | -134.81 |
| PEG Ratio | 0 |
| Price to Book value | 1.14 |
| Price to Sales | 3.24 |
| Price to Cash Flow | 6.48 |
| Dividend | 0.75 |
| Forward Dividend | 0 |
| Dividend Yield | 2.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|